SFL’s CEO and President of the Medtech & Pharma Platform (MPP) Association Shayesteh Fürst-Ladani is presenting at a joint MPP and Swiss Medtech MDR@noon experts webinar on the “Role of industry in shaping the regulatory environment for combined products” (14 October 2020, 12 noon CEST; online). Shayesteh’s presentation is entitled “The Medtech & Pharma Platform Association (MPP). What are combined products?”, and highlights the regulatory activities of the MPP, as well as the scope of combined products, which encompasses both combination products comprising a drug and device component, as well as other complex medical devices with a software and medtech and/or pharma component. Shayesteh will also answer participants’ questions in a Q&A session.

Shayesteh is President of the MPP Association and an expert in EU and US regulations including the EU MDR, having participated in reviewing and assessing the impact of legislation in these regions for both pharma and medical device products, as well as combined products with drug, device and software components. Furthermore, Shayesteh is a Lecturer in Regulatory Affairs at IFPMA/Kings College.

Contact SFL to arrange a call with Shayesteh and discuss how SFL’s interdisciplinary teams, covering Medical Devices and Combination Products, Regulatory Affairs, Medical Affairs, Quality Assurance and Supply Chain, can support you to ensure your medical devices and combined products conform to all requirements under the MDR and IVDR.